Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.85
-7.50
(-0.80%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences gains on getting two final approvals from USFDA for Venlafaxine, Pregabalin
>>
Zydus Lifesciences gets two final approvals from USFDA for Venlafaxine, Pregabalin
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences commences Phase IV clinical trial for Desidustat in patients with CKD induced anemia
>>
Zydus Lifesciences informs about loss of share certificate
>>
Zydus Lifesciences informs about newspaper publication
>>
Zydus Lifesciences surges on getting final approval from USFDA for Prochlorperazine Maleate tablets
>>
Zydus shines on getting final approval from USFDA for Prochlorperazine Maleate tablets
>>
Zydus Lifesciences gets final approval from USFDA for Prochlorperazine Maleate tablets
>>
Zydus Lifesciences - Quaterly Results
<<
<
60
61
62
...168
>
>>